Severe acute respiratory syndrome (SARS) - Paradigm of an emerging viral infection

Journal of Clinical Virology

Volumn 29, Issue 1, 2004, Pages 13-22

  Berger, A ^a   Drosten, Ch ^b   Doerr, H W ^a   Sturmer M ^a   Preiser, W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Antiviral treatment; Coronavirus; Emerging infection; Epidemiology; Laboratory diagnosis; SARS associated coronavirus (SARS CoV); Severe acute respiratory syndrome (SARS); Transmission; World Health Organization (WHO)

Indexed keywords

ALPHA INTERFERON; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; BETA INTERFERON; GAMMA INTERFERON; GLYCYRRHIZIC ACID; IMMUNOMODULATING AGENT; LOPINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RIBAVIRIN; RITONAVIR; VIRUS RNA; VIRUS VACCINE;

AMINO ACID SEQUENCE; ARTIFICIAL VENTILATION; CHINA; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE TRANSMISSION; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EPIDEMIOLOGICAL DATA; GENE SEQUENCE; HUMAN; IMMUNOFLUORESCENCE; LABORATORY DIAGNOSIS; MORTALITY; NONHUMAN; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SARS CORONAVIRUS; SEQUENCE HOMOLOGY; SERODIAGNOSIS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 0346850741     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2003.09.011     Document Type: Review

References (66)

1. Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 300:2003;1763-1767.
2. Booth C.M., Matukas L.M., Tomlinson G.A., Rachlis A.R., Rose D.B., Dwosh H.A.et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 289:2003;2801-2809.
3. Breiman R.F., Evans M.R., Preiser W., Maguire J., Schnur A., Bekedam H., MacKenzie J.S. Role of China in the Quest to Define and Control Severe Acute Respiratory Syndrome. Emerg. Infect. Dis. 9(9):2003;1037-1041.
4. Cavanagh, D. Coronaviruses and Toroviruses. In Zuckerman, AJ, Bantvala, JE, Pattison, JR, editors. Principles and practice of clinical virology. 2000. Wiley, Chichester.
5. Centers for Disease Control and Prevention. Update: Outbreak of severe acute respiratory syndrome-worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003;52:241-6,248.
6. Chan-Yeung M., Yu W.C. Outbreak of severe acute respiratory syndrome in Hong Kong special administrative region: case report. BMJ. 326:2003;850-852.
7. Chan-Yeung M., Seto W.H., Sung J.J. Severe acute respiratory syndrome: patients were epidemiologically linked. BMJ. 326:2003;1393.
8. Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 361:2003a;2045-2046.
9. Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Treatment of SARS with human interferons. Lancet. 362:2003;293-294.
10. Cyranoski D., Abbott A. Virus detectives seek source of SARS in China's wild animals. Nature. 423:2003;467.
11. Donnelly C.A., Ghani A.C., Leung G.M., Hedley A.J., Fraser C., Riley S. et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 361:2003;1761-1766.
12. Drosten C., Gunther S., Preiser W., van der W.S., Brodt H.R., Becker S. et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:2003a;1967-1976.
13. Drosten C., Preiser W., Günther S., Schmitz H., Doerr H.W. Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol. Med. 9:2003;325-327.
14. Dwosh H.A., Hong H.H., Austgarden D., Herman S., Schabas R. Identification and containment of an outbreak of SARS in a community hospital. CMAJ. 168:2003;1415-1420.
15. Enserink M. SARS in China. China's missed chance. Science. 301:2003a;294-296.
16. Enserink M. SARS in China. The big question now: will it be back? Science. 301:2003;299.
17. Fouchier R.A., Kuiken T., Schutten M., van Amerongen G., van Doornum G.J., van den Hoogen B.G.et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature. 423:2003;240.
18. Fowler R.A., Lapinsky S.E., Hallett D., Detsky A.S., Sibbald W.J., Slutsky A.S.et al. Critically ill patients with severe acute respiratory syndrome. JAMA. 290:2003;367-373.
19. Gold E.R. SARS genome patent: symptom or disease? Lancet. 361:2003;2002-2003.
20. Guan Y., Zheng B.J., He Y.Q., Liu X.L., Zhuang Z.X., Cheung C.L., Luo S.W., Li P.H., Zhang L.J., Guan Y.J., Butt K.M., Wong K.L., Chan K.W., Lim W., Shortridge K.F., Yuen K.Y., Peiris J.S., Poon L.L. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 302(5643):2003;276-278. Epub 2003 Sep 04.
21. Hawkey P.M., Bhagani S., Gillespie S.H. Severe acute respiratory syndrome (SARS): breath-taking progress. J. Med. Microbiol. 52:2003;609-613.
22. Hazelton P.R., Gelderblom H.R. Electron microscopy for rapid diagnosis of infectious agents in emergent situations. Emerg. Infect. Dis. 9:2003;294-303.
23. Holmes K.V. SARS coronavirus: a new challenge for prevention and therapy. J. Clin. Invest. 111:2003;1605-1609.
24. Hon K.L., Leung C.W., Cheng W.T., Chan P.K., Chu W.C., Kwan Y.W.et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet. 361:2003;1701-1703.
25. Hong Kong Department of Health. Outbreak of severe acute respiratory syndrome (SARS) at Amoy Gardens, Kowloon Bay, Hong Kong. Main findings of the investigation. Published online 17 April 2003. http://www.info.gov.hk/info/ap/ pdf/amoy_e.pdf .
26. Huang P., Ni H., Shen G., Zhou H., Peng G., Liu S. Analysis of the 1991-2000 influenza epidemic in Guangdong Province, China. Southeast Asian J. Trop. Med. Public Health. 32(4):2001;787-790.
27. Koren G., King S., Knowles S., Phillips E. Ribavirin in the treatment of SARS: a new trick for an old drug? Can. Med. Assoc. J. 168:2003;1289-1292.
28. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S.et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:2003;1953-1966.
29. Kuiken T., Fouchier R.A., Schutten M., Rimmelzwaan G.F., van Amerongen G., van Riel D.et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 362:2003;263-270.
30. Lai M.M., Cavanagh D. The molecular biology of coronaviruses. Adv. Virus Res. 48:1997;1-100.
31. Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M.et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348:2003;1986-1994.
32. Li G., Chen X., Xu A. Profile of specific antibodies to the SARS-associated coronavirus. N. Engl. J. Med. 349:2003;508-509.
33. Lin L., Han Y., Yang Z.M. Clinical observation on 103 patients of severe acute respiratory syndrome treated by integrative traditional Chinese and Western Medicine. Zhongguo Zhong. Xi. Yi. Jie. He. Za Zhi. 23:2003;409-413.
34. Lipsitch M., Cohen T., Cooper B., Robins J.M., Ma S., James L.et al. Transmission dynamics and control of severe acute respiratory syndrome. Science. 300:2003;1966-1970.
35. Liu J.P., Manheimer E., Tsutani K., Gluud C. Medicinal herbs for hepatitis C virus infection. Cochrane Database Syst. Rev. 4:2001;CD003183.
36. Ludwig B., Kraus F.B., Allwinn R., Doerr H.W., Preiser W. Viral zoonoses - a threat under control? Intervirology. 46:2003;71-78.
37. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S.et al. The Genome sequence of the SARS-associated coronavirus. Science. 300:2003;1399-1404.
38. Ng S.K.C. Possible role of an animal vector in the SARS outbreak at Amoy Gardens. Lancet. 362:2003;570-572.
39. Normile D., Enserink M. SARS in China. Tracking the roots of a killer. Science. 301:2003;297-299.
40. Peiris J.S., Chu C.M., Cheng V.C., Chan K.S., Hung I.F., Poon L.L.et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 361:2003a;1767-1772.
41. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W.et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 361:2003;1319-1325.
42. Pensaert M., Callebaut P., Vergote J. Isolation of a porcine respiratory, non-enteric coronavirus related to transmissible gastroenteritis. Vet. Q. 8:1986;257-261.
43. Poon L.L., Wong O.K., Chan K.H., Luk W., Yuen K.Y., Peiris J.S., Guan Y. Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin. Chem. 49:2003;953-955. Erratum in: Clin Chem 2003 Jul; 49 (7): 1234.
44. Poutanen S.M., Low D.E., Henry B., Finkelstein S., Rose D., Green K.et al. National microbiology laboratory, Canada; Canadian severe acute respiratory syndrome study team. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348:2003;1995-2005.
45. Rainer T.H., Cameron P.A., Smit D., Ong K.L., Hung A.N., Nin D.C.et al. Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMJ. 326:2003;1354-1358.
46. Reilley B., van Herp M., Sermand D., Dentico N. SARS and Carlo Urbani. N. Engl. J. Med. 348:2003;1951-1952.
47. Riley S., Fraser C., Donnelly C.A., Ghani A.C., Abu-Raddad L.J., Hedley A.J.et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 300:2003;1961-1966.
48. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P.et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 300:2003;1394-1399.
49. Ruan Y.J., Wei C.L., Ee A.L., Vega V.B., Thoreau H., Su S.T.et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet. 361:2003;1779-1785.
50. Seto W.H., Tsang D., Yung R.W., Ching T.Y., Ng T.K., Ho M.et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet. 361:2003;1519-1520.
51. Sizun J., Yu M.W., Talbot P.J. Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source of hospital-acquired infections. J. Hosp. Infect. 46:2000;55-60.
52. Snijder E.J., Bredenbeek P.J., Dobbe J.C., Thiel V., Ziebuhr J., Poon L.L., Guan Y., Rozanov M., Spaan W.J., Gorbalenya A.E. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331(5):2003;991-1004.
53. So L.K., Lau A.C., Yam L.Y., Cheung T.M., Poon E., Yung R.W.et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 361:2003;1615-1617.
54. Thiel V., Ivanov K.A., Putics A., Hertzig T., Schelle B., Bayer S., Weissbrich B., Snijder E.J., Rabenau H., Doerr H.W., Gorbalenya A.E., Ziebuhr J. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84:2003;1305-1315.
55. Tsang K.W., Ho P.L., Ooi G.C., Yee W.K., Wang T., Chan-Yeung M.et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348:2000;1977-1985.
56. Tsui S.K., Chim S.S., Lo Y.M. Chinese University of Hong Kong Molecular SARS Research Group. Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome. N. Engl. J. Med. 349:2003;187-188.
57. WHO Department of Communicable Disease Surveillance and Response: Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). World Health Organization: Geneva, 2003. WHO/CDS/CSR/GAR/2003. 11.
58. WHO Environmental Health Team: Report on Amoy Gardens. World Health Organization Regional Office for the Western Pacific. 16 May 2003. Available at http://www.info.gov.hk/info/ap/who-amoye.pdf .
59. Wong S.F., Chow K.M., de Swiet M. Severe acute respiratory syndrome and pregnancy. BJOG. 110:2003a;641-642.
60. Wong V.W., Dai D., Wu A.K., Sung J.J. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med. J. 9:2003;199-201.
61. World Health Organization (WHO). WHO multicentre collaborative networks for severe acute respiratory syndrome (SARS) diagnosis. Wkly Epidemiol Rec 2003a;78:121-2.
62. World Health Organization (WHO). Severe acute respiratory syndrome - Singapore, 2003. Wkly Epidemiol Rec 2003b;78:157-62.
63. World Health Organization (WHO). Severe acute respiratory syndrome (SARS): over 100 days into the outbreak. Wkly Epidemiol Rec 2003c;78:217-20.
64. World Health Organization (WHO). Chronology of travel recommendations, areas with local transmission. Wkly Epidemiol Rec 2003d;78:258-9.
65. World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome Diagnosis. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003;361:1730-3.
66. Zhao Z., Zhang F., Xu M., Huang K., Zhong W., Cai W.et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J. Med. Microbiol. 52:2003;715-720.